| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥30.2B | ¥31.9B | -5.5% |
| Operating Income | ¥-3.1B | ¥-1.1B | -187.0% |
| Ordinary Income | ¥-3.3B | ¥-1.0B | -234.7% |
| Net Income | ¥-2.5B | ¥-1.0B | -139.7% |
| ROE | -9.7% | -5.7% | - |
FY2025 Q3 cumulative results: Revenue of 30.2B yen (YoY -5.5%), Operating Loss of -3.1B yen (prior period -1.1B yen, deterioration of -2.0B yen), Ordinary Loss of -3.3B yen (prior period -1.0B yen, YoY -234.7%), Net Loss of -2.5B yen (prior period -1.0B yen, YoY -139.7%). The company recorded deeper losses across all profit levels despite maintaining a gross profit margin of 28.0%. The operating loss expansion from -1.1B yen to -3.1B yen was driven by declining revenue combined with elevated SG&A expenses of 11.5B yen (38.2% of revenue), particularly corporate overhead costs of approximately 0.4B yen. Total assets increased to 89.8B yen from 86.8B yen, while equity rose to 25.4B yen from 18.0B yen. However, financial leverage remains elevated at 3.54x with interest-bearing debt of 37.1B yen generating interest expenses of 0.7B yen, resulting in negative interest coverage of -4.37x. Cash position improved to 23.5B yen from 18.1B yen, and short-term borrowings decreased significantly to 5.2B yen from 12.2B yen, indicating improved short-term liquidity despite operational challenges.
Revenue declined 5.5% YoY to 30.2B yen, with all three reporting segments experiencing headwinds. The Optics segment generated 13.3B yen in revenue (down from 13.8B yen prior period), representing the largest revenue contributor. The Functional Thin Film and Glass segment recorded 9.0B yen (down from 9.9B yen), while the Lighting segment contributed 3.3B yen (down from 3.9B yen). The Other segment, comprising medical glass products such as dental mirrors and washing machine door glass, generated 4.7B yen (up from 4.4B yen), showing relative resilience.
At the profit level, gross profit of 8.4B yen translated to a 28.0% margin, indicating acceptable product-level profitability. However, SG&A expenses of 11.5B yen (38.2% of revenue) exceeded gross profit, with key components including salaries of 3.5B yen, depreciation of 0.5B yen, and R&D expenses of 1.0B yen (3.2% of revenue). The SG&A burden relative to declining revenue drove the operating loss expansion. Corporate overhead costs not allocated to segments totaled approximately 0.4B yen, representing structural fixed costs that compressed segment-level profits into consolidated operating losses.
Non-operating items added further pressure, with net non-operating expenses of 0.2B yen comprising non-operating income of 0.7B yen (including FX gains of 0.2B yen) offset by non-operating expenses of 0.9B yen (primarily interest expenses of 0.7B yen). This interest burden reflects the company's debt structure of 37.1B yen in interest-bearing liabilities, yielding an interest coverage ratio of -4.37x. The gap between ordinary loss of -3.3B yen and operating loss of -3.1B yen is modest at 0.2B yen, indicating limited non-operating impact. Tax benefits of 0.7B yen reduced the net loss to -2.5B yen from pre-tax loss of -3.2B yen. This represents a "revenue down, profit down" pattern, with top-line contraction and fixed cost deleverage driving deteriorating profitability across all levels.
The Optics segment is the core business, generating 13.3B yen in revenue (44.0% of total consolidated revenue) and operating profit of 0.9B yen with a 6.6% margin. This segment showed resilience with positive profitability despite revenue declining from 13.8B yen in the prior period, with operating profit decreasing from 2.0B yen to 0.9B yen.
The Functional Thin Film and Glass segment recorded 9.0B yen in revenue (29.8% of total) but posted an operating loss of -0.5B yen (margin of -5.6%). This represents a significant deterioration from the prior period's operating profit of 0.4B yen, indicating structural challenges in this segment's cost structure or pricing environment.
The Lighting segment contributed 3.3B yen in revenue (10.9% of total) with minimal operating profit of 0.1B yen (1.6% margin), down sharply from the prior period's operating loss of -0.3B yen, showing some operational improvement but still operating near breakeven.
The Other segment, while smaller at 4.7B yen in revenue (15.5% of total), generated operating profit of 0.4B yen with a 9.5% margin, representing the highest margin among all segments and providing important profit contribution despite its smaller scale.
Segment-level operating profits totaled 0.9B yen (Optics 0.9B yen + Lighting 0.1B yen + Other 0.4B yen, offset by Functional Thin Film loss of -0.5B yen), but corporate overhead costs of 0.4B yen not allocated to segments resulted in consolidated operating loss of -3.1B yen. The margin disparity across segments highlights the profitability concentration in Optics and Other segments, while Functional Thin Film faces margin pressure requiring operational restructuring.
[Profitability] ROE of -9.7% reflects the impact of net losses on equity returns, significantly below the manufacturing industry median of 5.8%. Operating margin of -10.3% compares unfavorably to the industry median of 8.9%, indicating substantial structural cost challenges. Net profit margin of -8.2% is deeply negative versus the industry median of 6.5%, driven by both operational losses and interest burden. Gross margin of 28.0% suggests product-level pricing power exists, but SG&A ratio of 38.2% overwhelms this gross profitability. EBIT margin of -10.3% and interest burden coefficient of 1.037 highlight how operating losses are compounded by financial costs. [Asset Efficiency] Total asset turnover of 0.336 is materially below the industry median of 0.56, indicating underutilization of the asset base of 89.8B yen. Property, plant and equipment of 37.3B yen represents 41.5% of total assets, reflecting capital-intensive operations. Inventory turnover of 194.1 days significantly exceeds the industry median of 112.3 days, with inventories of 5.1B yen increasing 40.6% YoY, indicating accumulation of work-in-process of 7.3B yen. Receivables turnover of 86.9 days aligns with the industry median of 85.4 days, though receivables declined 34.7% to 7.2B yen reflecting both collection improvement and revenue decline. Operating working capital turnover of 155.7 days exceeds the industry median of 111.5 days, suggesting working capital inefficiency. [Financial Health] Equity ratio of 28.3% is substantially below the industry median of 63.8%, indicating high leverage. Debt-to-equity ratio of 2.54 exceeds the 2.0x threshold and industry median of approximately 0.53 (implied from median financial leverage of 1.53), triggering leverage warnings. Current ratio of 196.3% and quick ratio of 175.3% indicate adequate short-term liquidity, with current assets of 47.3B yen covering current liabilities of 24.1B yen by nearly 2x. Interest-bearing debt totals 37.1B yen (short-term 5.2B yen, long-term 31.9B yen), with interest expenses of 0.7B yen yielding negative interest coverage of -4.37x versus operating income, indicating debt servicing capacity concerns. Cash and deposits of 23.5B yen provide 4.5x coverage of short-term debt, supporting near-term liquidity. [Investment Efficiency] ROIC and ROA are negative due to operating losses, with ROA of -2.8% versus industry median of 3.4%, highlighting poor capital returns. Financial leverage of 3.54 exceeds the industry median of 1.53, amplifying negative returns through the balance sheet structure.
Cash and deposits increased 5.4B yen YoY to 23.5B yen, representing 29.8% growth and indicating improved liquidity position despite operating losses. This cash accumulation reflects several balance sheet movements: short-term borrowings decreased substantially by 7.0B yen from 12.2B yen to 5.2B yen, suggesting debt repayment or restructuring that freed up working capital. Working capital composition shifted materially, with trade receivables declining 3.8B yen (34.7% decrease) from 11.0B yen to 7.2B yen, contributing positively to cash through accelerated collections or revenue-driven reduction. Conversely, inventories increased 1.5B yen (40.6%) from 3.6B yen to 5.1B yen, with work-in-process expanding to 7.3B yen, representing cash consumption through production buildup. Trade payables decreased 1.1B yen from 2.6B yen to 1.5B yen, indicating supplier payment outflows. The net effect of these working capital movements, combined with the substantial reduction in short-term debt, resulted in overall cash position improvement. Total equity increased 7.4B yen from 18.0B yen to 25.4B yen despite the net loss of 2.5B yen, suggesting potential capital injections or other equity increases that supported the balance sheet. The liquidity metrics show cash coverage of short-term debt at 4.5x (23.5B yen cash versus 5.2B yen short-term borrowings), indicating strong near-term payment capacity. However, the inventory buildup and elevated work-in-process levels of 7.3B yen suggest working capital efficiency deterioration that could constrain future cash generation if not addressed through production optimization and inventory reduction.
Ordinary income of -3.3B yen versus operating income of -3.1B yen shows net non-operating contribution of approximately -0.2B yen, comprising non-operating income of 0.7B yen offset by non-operating expenses of 0.9B yen. Non-operating income includes FX gains of 0.2B yen and other miscellaneous income of 0.1B yen, while non-operating expenses are dominated by interest expenses of 0.7B yen reflecting the cost of 37.1B yen in interest-bearing debt. Non-operating income of 0.7B yen represents 2.3% of revenue, indicating modest contribution from non-core activities. Extraordinary items were minimal, with extraordinary income of 0.1B yen from asset sales and negligible extraordinary losses, totaling net extraordinary gain of approximately 0.1B yen or 0.3% of revenue. The distinction between recurring and non-recurring factors shows operating losses are structural rather than driven by one-time charges. Comprehensive income of -2.3B yen is marginally better than net income of -2.5B yen, with positive contributions from FX translation adjustments of 0.1B yen and valuation gains on securities of 0.1B yen. The relatively small gap between operating and ordinary income indicates earnings are primarily driven by core operations, with financial costs representing the main non-operating drag. Without disclosed operating cash flow data, earnings quality assessment relies on balance sheet indicators: the cash position increase despite net losses suggests some cash generation, but inventory accumulation of 1.5B yen and work-in-process buildup indicate potential accruals risk where reported earnings may not fully convert to cash. The negative interest coverage ratio of -4.37x and EBIT margin of -10.3% highlight that current earnings cannot service financial obligations from operations, raising sustainability concerns.
Full-year guidance projects revenue of 46.9B yen (YoY +0.1%), operating loss of -1.2B yen, ordinary loss of -1.2B yen, and net loss of -1.3B yen with EPS forecast of -5.04 yen. Q3 cumulative progress rates stand at 64.4% for revenue (30.2B yen / 46.9B yen), materially above the standard 75% benchmark for Q3, indicating the company is tracking slightly below full-year revenue targets. For operating income, the Q3 cumulative loss of -3.1B yen already exceeds the full-year loss forecast of -1.2B yen by 258.3%, indicating substantial underperformance against guidance. This significant negative deviation suggests either conservative remaining-quarter assumptions or potential for further guidance revision. The company disclosed a forecast revision this quarter, though specific revision amounts are not detailed in the provided data. The Q4 implied performance (full-year minus Q3 cumulative) suggests revenue of 16.7B yen in Q4 (46.9B yen - 30.2B yen), requiring 55.3% sequential growth from the Q3 cumulative run rate, which appears ambitious given current trends. For profitability, achieving the full-year operating loss guidance of -1.2B yen would require Q4 operating profit of approximately 1.9B yen (to offset the Q3 cumulative loss of -3.1B yen), implying a dramatic operational turnaround in the final quarter. Forecast notes indicate that projections are based on currently available information and certain assumptions, with actual results subject to material variation. The substantial gap between Q3 progress and full-year targets, particularly for profitability, warrants close monitoring of Q4 execution and potential for additional guidance revision. No order backlog data is available to assess forward revenue visibility, though the inventory buildup to 5.1B yen and elevated work-in-process of 7.3B yen may suggest some production in anticipation of future orders.
The company has declared zero dividend for the current period and forecasts zero dividend for the full fiscal year. With no dividend payment and net losses, the payout ratio is not applicable. No share buyback activity is disclosed in the available data. The absence of shareholder returns reflects the company's financial position with operating losses of -3.1B yen, net losses of -2.5B yen, and the need to preserve capital amid negative profitability. The dividend suspension aligns with the priority of maintaining financial stability, reducing leverage (D/E of 2.54), and managing interest-bearing debt of 37.1B yen that generates 0.7B yen in annual interest expenses. With retained earnings declining to 0.4B yen from 2.9B yen (down 85.1% YoY) due to cumulative losses, the company has limited distributable reserves. Free cash flow is not disclosed, but the cash position improvement to 23.5B yen despite operational losses suggests some liquidity management success, though insufficient to support dividends while addressing structural profitability challenges. The total return ratio (dividends plus buybacks divided by net income) cannot be calculated given zero distributions and negative earnings. Dividend restoration will likely require sustained return to profitability, interest coverage improvement from current -4.37x, and deleveraging to strengthen the balance sheet for sustainable shareholder distributions.
Operating leverage risk: Fixed cost structure with SG&A of 11.5B yen (38.2% of revenue) including corporate overhead of approximately 0.4B yen creates significant downside sensitivity to revenue fluctuations. The 5.5% revenue decline drove operating loss expansion from -1.1B yen to -3.1B yen, demonstrating negative operating leverage. With capital-intensive assets of 37.3B yen in PPE and depreciation of 0.5B yen, the company requires sustained revenue growth to achieve operating leverage benefits and return to profitability.
Working capital efficiency risk: Inventory increased 40.6% YoY to 5.1B yen with work-in-process elevated at 7.3B yen, yielding inventory turnover of 194.1 days versus industry median of 112.3 days. This 82-day excess represents approximately 4.5B yen in potential cash tied up in slow-moving inventory. Operating working capital turnover of 155.7 days exceeds industry median by 44 days, indicating structural inefficiency. If inventory cannot be converted to sales efficiently, further cash consumption and potential obsolescence write-downs could materialize, with quantified exposure of 1.5B yen in YoY inventory growth.
Financial risk from leverage and interest burden: Debt-to-equity ratio of 2.54 exceeds the 2.0x threshold with interest-bearing debt of 37.1B yen generating 0.7B yen annual interest expense. Interest coverage of -4.37x indicates current operations cannot service debt obligations. Net debt to EBITDA cannot be calculated due to negative EBITDA, but interest expense represents 2.3% of revenue, consuming gross profit. Long-term debt of 31.9B yen requires refinancing management, and any interest rate increases or tightening credit conditions could materially impair financial flexibility. The high leverage amplifies downside risk through financial leverage of 3.54x, with each 1% decline in asset returns magnified 3.54x on equity returns.
[Industry Position] (Reference - Proprietary Analysis)
The company's financial metrics show material divergence from manufacturing industry medians across profitability, efficiency, and financial health dimensions.
Profitability: ROE of -9.7% significantly underperforms the industry median of 5.8% (2025-Q3, n=105), representing a 15.5 percentage point gap. Operating margin of -10.3% contrasts with the industry median of 8.9%, a 19.2 percentage point deficit reflecting structural cost challenges. Net profit margin of -8.2% versus industry median of 6.5% demonstrates bottom-line underperformance. The negative margins indicate the company is in the bottom quartile of industry profitability distribution.
Financial Health: Equity ratio of 28.3% is substantially below the industry median of 63.8%, positioning the company in the lowest quartile for balance sheet strength with high leverage. The debt-to-equity ratio of 2.54 contrasts with the implied industry median of approximately 0.53 (derived from median financial leverage of 1.53), indicating leverage approximately 4.8x industry norms. Current ratio of 196.3% compares favorably to the industry median of 287%, though still adequate for short-term liquidity.
Efficiency: Operating margin of -10.3% versus industry median of 8.9% and asset turnover of 0.336 versus industry median of 0.56 indicate both margin and turnover disadvantages. Inventory turnover of 194.1 days exceeds industry median of 112.3 days by 82 days, representing significant working capital inefficiency. Receivables turnover of 86.9 days aligns with industry median of 85.4 days, showing relative competitiveness in collections. Operating working capital turnover of 155.7 days versus industry median of 111.5 days demonstrates overall working capital cycle inefficiency of 44 additional days.
Growth: Revenue growth of -5.5% YoY underperforms the industry median growth of 2.8%, representing an 8.3 percentage point growth gap and placing the company below median in top-line momentum. EPS growth of -116.1% (from -4.42 yen to -9.55 yen) contrasts with industry median EPS growth of 9%, reflecting deteriorating profitability trends.
The company ranks in the bottom quartile across most financial metrics within the manufacturing industry, with leverage, profitability, and efficiency measures substantially below peers. The negative interest coverage and elevated D/E ratio represent the most material risk factors requiring remediation to achieve industry-median financial health.
(Industry: Manufacturing (n=105 companies), Comparison: 2025-Q3 period, Source: Proprietary Analysis)
Key Takeaways from Earnings:
Structural profitability challenge requires operational restructuring. The company demonstrates an inverted profit structure where SG&A expenses of 11.5B yen (38.2% of revenue) exceed gross profit of 8.4B yen (28.0% margin), resulting in operating losses of -3.1B yen. The corporate overhead allocation of approximately 0.4B yen represents non-value-adding costs that compress segment profitability into consolidated losses. Historical trend shows operating loss expansion from -1.1B yen to -3.1B yen year-over-year despite only modest 5.5% revenue decline, indicating negative operating leverage. The Functional Thin Film and Glass segment shifted from 0.4B yen profit to -0.5B yen loss, while Optics segment profit halved from 2.0B yen to 0.9B yen. These trends suggest the current cost structure is unsustainable at current revenue levels, requiring either revenue growth acceleration or structural cost reduction through headcount optimization, manufacturing footprint rationalization, or segment exit to achieve breakeven.
Working capital inefficiency creates cash generation headwind. Inventory increased 40.6% YoY to 5.1B yen with work-in-process reaching 7.3B yen, extending inventory days to 194.1 versus industry median of 112.3, representing 82 excess days or approximately 4.5B yen in trapped working capital. The buildup suggests either demand forecasting misalignment, production inefficiency, or elongated manufacturing cycles in the capital-intensive glass and optical manufacturing processes. Trade receivables declined 34.7% to 7.2B yen, reducing DSO to 86.9 days (aligned with industry), but this reflects both improved collections and lower revenue. Operating working capital cycle of 155.7 days exceeds industry by 44 days, indicating a structural competitive disadvantage in cash conversion. Improvement in working capital efficiency through inventory reduction and production cycle optimization could free material cash for debt reduction and represent a key near-term value creation lever without requiring revenue growth.
High financial leverage constrains strategic flexibility and amplifies downside risk. Debt-to-equity of 2.54 with interest-bearing debt of 37.1B yen and equity of only 25.4B yen creates interest expenses of 0.7B yen that cannot be covered by operating income, yielding negative interest coverage of -4.37x. Long-term debt of 31.9B yen has refinancing risk if credit conditions tighten or profitability does not recover. The equity ratio of 28.3% versus industry median of 63.8% positions the company in the bottom quartile for financial strength. Financial leverage of 3.54x amplifies returns but magnifies negative ROE to -9.7% from already negative operating returns. The cash position improvement to 23.5B yen and short-term debt reduction to 5.2B yen demonstrate liquidity management capability, but the structural leverage issue requires either sustained profitability recovery to rebuild equity through retained earnings, equity capital raises to recapitalize the balance sheet, or asset sales to delever. The debt burden limits strategic investment capacity and creates vulnerability to adverse operating or market conditions.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.